In both models, the frequencies of tumor infiltrating CD8+ T cells without inhibitory receptor expression (4 IhR−) significantly increased in chemo-immunotherapy compared with PBS controls (AB1-HA: p=0.01; CT26: p=0.04; figure 5G). The gene discussed is CD8A; the disease is neoplasm.